Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine–associated anaphylaxis
Background Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine–associated anaphylaxis (IVA) do not always have egg allergy. In the 2011-2012 season, an unusually high incidence of IVA was reported in Japan....
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 137; no. 3; pp. 861 - 867 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2016
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine–associated anaphylaxis (IVA) do not always have egg allergy. In the 2011-2012 season, an unusually high incidence of IVA was reported in Japan. Objective We sought to identify the cause of the increase in anaphylactic events in 2011-2012 in Japan. Methods We collected blood specimens from patients with IVA from all areas of Japan. We analyzed 19 patients with confirmed IVA and 25 age-matched control subjects, including 10 with egg allergy who had no adverse events after corresponding vaccination. ELISA was used to measure specific IgE levels to the trivalent vaccines of several manufacturers and hemagglutinin proteins derived from both egg and cell cultures. Antigen-induced basophil activation was evaluated by measuring CD203c expression by means of flow cytometry. Vaccine excipients were also examined for effects on CD203c expression. Results None of the patients with IVA had severe egg allergy. Levels of specific IgE antibodies to influenza vaccine antigens, whole-vaccine products from different manufacturers, and hemagglutinin proteins (A H1, H3, and B) derived from both egg and cell cultures were significantly increased in patients with IVA compared with those in control subjects. Influenza vaccine–induced CD203c expression in basophils was also highly enhanced in patients with IVA but not in control subjects. Because IVA was most frequent in patients who received 2-phenoxyethanol (2-PE)–containing vaccine, the effect of this preservative on basophil activation was examined, and the activation was slightly enhanced by 2-PE but not thimerosal. Conclusions The 2011-2012 IVA spike in Japan was caused by specific IgE antibodies to influenza vaccine components. Excipients could not be implicated, except for a modest effect of 2-PE. |
---|---|
AbstractList | Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine-associated anaphylaxis (IVA) do not always have egg allergy. In the 2011-2012 season, an unusually high incidence of IVA was reported in Japan.
We sought to identify the cause of the increase in anaphylactic events in 2011-2012 in Japan.
We collected blood specimens from patients with IVA from all areas of Japan. We analyzed 19 patients with confirmed IVA and 25 age-matched control subjects, including 10 with egg allergy who had no adverse events after corresponding vaccination. ELISA was used to measure specific IgE levels to the trivalent vaccines of several manufacturers and hemagglutinin proteins derived from both egg and cell cultures. Antigen-induced basophil activation was evaluated by measuring CD203c expression by means of flow cytometry. Vaccine excipients were also examined for effects on CD203c expression.
None of the patients with IVA had severe egg allergy. Levels of specific IgE antibodies to influenza vaccine antigens, whole-vaccine products from different manufacturers, and hemagglutinin proteins (A H1, H3, and B) derived from both egg and cell cultures were significantly increased in patients with IVA compared with those in control subjects. Influenza vaccine-induced CD203c expression in basophils was also highly enhanced in patients with IVA but not in control subjects. Because IVA was most frequent in patients who received 2-phenoxyethanol (2-PE)-containing vaccine, the effect of this preservative on basophil activation was examined, and the activation was slightly enhanced by 2-PE but not thimerosal.
The 2011-2012 IVA spike in Japan was caused by specific IgE antibodies to influenza vaccine components. Excipients could not be implicated, except for a modest effect of 2-PE. Background Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine-associated anaphylaxis (IVA) do not always have egg allergy. In the 2011-2012 season, an unusually high incidence of IVA was reported in Japan. Objective We sought to identify the cause of the increase in anaphylactic events in 2011-2012 in Japan. Methods We collected blood specimens from patients with IVA from all areas of Japan. We analyzed 19 patients with confirmed IVA and 25 age-matched control subjects, including 10 with egg allergy who had no adverse events after corresponding vaccination. ELISA was used to measure specific IgE levels to the trivalent vaccines of several manufacturers and hemagglutinin proteins derived from both egg and cell cultures. Antigen-induced basophil activation was evaluated by measuring CD203c expression by means of flow cytometry. Vaccine excipients were also examined for effects on CD203c expression. Results None of the patients with IVA had severe egg allergy. Levels of specific IgE antibodies to influenza vaccine antigens, whole-vaccine products from different manufacturers, and hemagglutinin proteins (A H1, H3, and B) derived from both egg and cell cultures were significantly increased in patients with IVA compared with those in control subjects. Influenza vaccine-induced CD203c expression in basophils was also highly enhanced in patients with IVA but not in control subjects. Because IVA was most frequent in patients who received 2-phenoxyethanol (2-PE)-containing vaccine, the effect of this preservative on basophil activation was examined, and the activation was slightly enhanced by 2-PE but not thimerosal. Conclusions The 2011-2012 IVA spike in Japan was caused by specific IgE antibodies to influenza vaccine components. Excipients could not be implicated, except for a modest effect of 2-PE. BACKGROUNDInfluenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine-associated anaphylaxis (IVA) do not always have egg allergy. In the 2011-2012 season, an unusually high incidence of IVA was reported in Japan.OBJECTIVEWe sought to identify the cause of the increase in anaphylactic events in 2011-2012 in Japan.METHODSWe collected blood specimens from patients with IVA from all areas of Japan. We analyzed 19 patients with confirmed IVA and 25 age-matched control subjects, including 10 with egg allergy who had no adverse events after corresponding vaccination. ELISA was used to measure specific IgE levels to the trivalent vaccines of several manufacturers and hemagglutinin proteins derived from both egg and cell cultures. Antigen-induced basophil activation was evaluated by measuring CD203c expression by means of flow cytometry. Vaccine excipients were also examined for effects on CD203c expression.RESULTSNone of the patients with IVA had severe egg allergy. Levels of specific IgE antibodies to influenza vaccine antigens, whole-vaccine products from different manufacturers, and hemagglutinin proteins (A H1, H3, and B) derived from both egg and cell cultures were significantly increased in patients with IVA compared with those in control subjects. Influenza vaccine-induced CD203c expression in basophils was also highly enhanced in patients with IVA but not in control subjects. Because IVA was most frequent in patients who received 2-phenoxyethanol (2-PE)-containing vaccine, the effect of this preservative on basophil activation was examined, and the activation was slightly enhanced by 2-PE but not thimerosal.CONCLUSIONSThe 2011-2012 IVA spike in Japan was caused by specific IgE antibodies to influenza vaccine components. Excipients could not be implicated, except for a modest effect of 2-PE. |
Author | Ihara, Toshiaki, MD, PhD Kino, Yoichiro, MSc, PhD Nagao, Mizuho, MD, PhD Fujisawa, Takao, MD, PhD |
Author_xml | – sequence: 1 fullname: Nagao, Mizuho, MD, PhD – sequence: 2 fullname: Fujisawa, Takao, MD, PhD – sequence: 3 fullname: Ihara, Toshiaki, MD, PhD – sequence: 4 fullname: Kino, Yoichiro, MSc, PhD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26365388$$D View this record in MEDLINE/PubMed |
BookMark | eNqNktFqFDEUhoNU7Lb6Al7IgDfezHiSzCQZEKGUagsFL9TrkM2c6WbNJutkZnX1xnfwDX0SM2yr0AuRXISE7_85h_8_IUchBiTkKYWKAhUv19XaWFcxoE0FqgKgD8iCQitLoVhzRBYALS2FrNtjcpLSGvKbq_YROWaCi4YrtSDfL93Nyu8LF-yAJmFXeNyhT0Xsi6ubi8KE0S1j5zAVYyx2xloXsLBxs82zhDFlYWFXzncDhuKLG1f5o_cThm_mjv7146dJKVpnxmxvgtmu9t58dekxedgbn_DJ7X1KPr65-HB-WV6_e3t1fnZd2oaKsWScdpzJfBh2sgXoa8VgWdsal6qjyjbAhWqgbTgXNbUtGCkobUG1wjBAfkpeHHy3Q_w8YRr1xiWL3puAcUqaSslbypUU_4PSulZUzOjze-g6TkPIi2RKgWBSMsgUO1B2iCkN2Ovt4DZm2GsKek5Rr_Wcop5T1KB0TjGLnt1aT8sNdn8kd7Fl4NUByEnhzuGgk3UYLHZuQDvqLrp_-7--J7feBWeN_4R7TH_30Ilp0O_nHs01og3kejWS_wbtq8RE |
CitedBy_id | crossref_primary_10_1016_j_reval_2018_02_219 crossref_primary_10_1055_a_1353_1387 crossref_primary_10_4103_jopp_jopp_17_23 crossref_primary_10_1016_j_envres_2016_10_028 crossref_primary_10_1016_j_jaci_2017_12_971 crossref_primary_10_1128_mSphere_00245_17 crossref_primary_10_1007_s40521_022_00311_8 crossref_primary_10_1007_s13577_021_00618_9 crossref_primary_10_1371_journal_pntd_0005951 crossref_primary_10_1111_bcp_14112 crossref_primary_10_1080_1744666X_2020_1814745 crossref_primary_10_1111_pai_12762 crossref_primary_10_3820_jjpe_20_55 crossref_primary_10_1016_j_anai_2018_02_007 crossref_primary_10_1016_j_jaip_2021_08_002 crossref_primary_10_3388_jspaci_36_532 crossref_primary_10_4168_aair_2020_12_2_359 crossref_primary_10_1016_j_amsu_2018_09_014 crossref_primary_10_1016_j_vaccine_2017_01_008 crossref_primary_10_1016_j_vaccine_2018_11_045 crossref_primary_10_1213_XAA_0000000000000686 crossref_primary_10_1128_CVI_00092_16 crossref_primary_10_1016_j_jaci_2016_02_010 crossref_primary_10_1111_irv_13053 crossref_primary_10_3390_pharmaceutics12030267 crossref_primary_10_1016_j_jacig_2022_01_003 crossref_primary_10_1111_cea_13184 crossref_primary_10_1080_21645515_2018_1498435 crossref_primary_10_21508_1027_4065_2018_63_4_15_22 |
Cites_doi | 10.1111/j.1365-2222.2011.03842.x 10.1136/bmjopen-2011-000186 10.1111/cea.12059 10.1016/S0091-6749(96)80191-6 10.1016/j.vaccine.2004.06.042 10.1016/j.jaci.2012.07.046 10.1016/j.jaci.2012.07.019 10.1016/j.anai.2012.09.011 10.1093/cid/ciu948 10.1067/mai.2000.108433 10.1111/j.0105-1873.2006.0645g.x 10.1016/j.vaccine.2007.02.064 10.1016/S0264-410X(97)00214-4 10.1684/ejd.2012.1842 10.7150/ijms.8.239 10.1034/j.1600-0536.2002.470116.x 10.1016/j.jaci.2010.03.009 10.2147/JIR.S34152 10.1034/j.1398-9995.2001.00218.x |
ContentType | Journal Article |
Copyright | The Authors 2015 The Authors Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited Mar 2016 |
Copyright_xml | – notice: The Authors – notice: 2015 The Authors – notice: Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Mar 2016 |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7SS 7T5 H94 K9. NAPCQ 7X8 7U9 |
DOI | 10.1016/j.jaci.2015.08.001 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Virology and AIDS Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic Virology and AIDS Abstracts |
DatabaseTitleList | MEDLINE Entomology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 867 |
ExternalDocumentID | 4020560541 10_1016_j_jaci_2015_08_001 26365388 S0091674915010957 1_s2_0_S0091674915010957 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GrantInformation_xml | – fundername: Chemo-Sero-Therapeutic Research Institute |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 3V. 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 8C1 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFO ACGFS ACPRK ACRLP ADBBV ADEZE ADFRT ADMUD ADVLN AEBSH AEKER AENEX AFFNX AFJKZ AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BBNVY BENPR BHPHI BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HCIFZ HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M2O M41 M7P MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM 6I. AAFTH ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7SS 7T5 H94 K9. NAPCQ 7X8 7U9 |
ID | FETCH-LOGICAL-c516t-231d3272722ed7900f4820b4c4eb8d18c50368509533641c90a761190896a20e3 |
IEDL.DBID | AIKHN |
ISSN | 0091-6749 |
IngestDate | Thu Aug 15 22:17:26 EDT 2024 Sat Aug 17 00:21:22 EDT 2024 Thu Oct 10 20:30:52 EDT 2024 Thu Sep 26 15:50:17 EDT 2024 Sat Sep 28 07:58:56 EDT 2024 Fri Feb 23 02:34:44 EST 2024 Tue Oct 15 22:55:45 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | influenza vaccine Egg allergy group hemagglutinin IgE 2-PE No egg allergy group N group Influenza vaccine–associated anaphylaxis Anaphylaxis 2-Phenoxyethanol IVA basophil activation CRTH2 EA group Chemoattractant receptor-homologous molecule express on T H2 lymphocytes |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c516t-231d3272722ed7900f4820b4c4eb8d18c50368509533641c90a761190896a20e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9196-9436 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0091674915010957 |
PMID | 26365388 |
PQID | 1780627720 |
PQPubID | 105664 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1773913876 proquest_miscellaneous_1771448166 proquest_journals_1780627720 crossref_primary_10_1016_j_jaci_2015_08_001 pubmed_primary_26365388 elsevier_sciencedirect_doi_10_1016_j_jaci_2015_08_001 elsevier_clinicalkeyesjournals_1_s2_0_S0091674915010957 |
PublicationCentury | 2000 |
PublicationDate | 2016-03-01 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: St. Louis |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationTitleAlternate | J Allergy Clin Immunol |
PublicationYear | 2016 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Bohn, Bircher (bib21) 2001; 56 Nakayama, Aizawa (bib11) 2000; 106 Smith-Norowitz, Wong, Kusonruksa, Norowitz, Joks, Durkin (bib16) 2011; 8 Erlewyn-Lajeunesse, Lucas, Warner (bib8) 2011; 41 Des Roches, Paradis, Gagnon, Lemire, Bégin, Carr (bib2) 2012; 130 Accessed August 21, 2015. Greenhawt, Spergel, Rank, Green, Mansoor, Sharma (bib3) 2012; 109 Grohskopf, Olsen, Sokolow, Bresee, Cox, Broder (bib4) 2014; 63 Grotto, Mandel, Ephros, Ashkenazi, Shemer (bib13) 1998; 16 Parisi, Smaldini, Gervasoni, Maspero, Docena (bib12) 2013; 43 Nunez Orjales, Carballas Vazquez, Carballada Gonzalez, Boquete Paris (bib22) 2010; 20 Hernandez, Ortiz-Frutos, Garcia, Palencia, Garcia, Iglesias (bib20) 2002; 47 Barbaud, Deschildre, Waton, Raison-Peyron, Trechot (bib14) 2013; 23 Smith-Norowitz, Kusonruksa, Wong, Norowitz, Joks, Durkin (bib17) 2012; 5 Li, Rank, Squillace, Kita (bib6) 2010; 125 Woo (bib9) 2015; 60 Sakaguchi, Nakayama, Inouye (bib10) 1996; 98 Russell, Pool, Kelso, Tomazic-Jezic (bib15) 2004; 23 Rouleau, De Serres, Drolet, Banerjee, Lemire, Moore (bib18) 2012; 130 Forsdahl (bib1) 2012; 2 Ruggeberg, Gold, Bayas, Blum, Bonhoeffer, Friedlander (bib7) 2007; 25 Centers for Disease Control and Prevention. Frequently asked questions about thimerosal (ethylmercury). (bib5) 2005; 927 Birnie, English (bib19) 2006; 54 Erlewyn-Lajeunesse (10.1016/j.jaci.2015.08.001_bib8) 2011; 41 (10.1016/j.jaci.2015.08.001_bib5) 2005; 927 Hernandez (10.1016/j.jaci.2015.08.001_bib20) 2002; 47 10.1016/j.jaci.2015.08.001_bib23 Forsdahl (10.1016/j.jaci.2015.08.001_bib1) 2012; 2 Smith-Norowitz (10.1016/j.jaci.2015.08.001_bib16) 2011; 8 Nunez Orjales (10.1016/j.jaci.2015.08.001_bib22) 2010; 20 Woo (10.1016/j.jaci.2015.08.001_bib9) 2015; 60 Li (10.1016/j.jaci.2015.08.001_bib6) 2010; 125 Sakaguchi (10.1016/j.jaci.2015.08.001_bib10) 1996; 98 Russell (10.1016/j.jaci.2015.08.001_bib15) 2004; 23 Rouleau (10.1016/j.jaci.2015.08.001_bib18) 2012; 130 Greenhawt (10.1016/j.jaci.2015.08.001_bib3) 2012; 109 Bohn (10.1016/j.jaci.2015.08.001_bib21) 2001; 56 Des Roches (10.1016/j.jaci.2015.08.001_bib2) 2012; 130 Nakayama (10.1016/j.jaci.2015.08.001_bib11) 2000; 106 Grotto (10.1016/j.jaci.2015.08.001_bib13) 1998; 16 Grohskopf (10.1016/j.jaci.2015.08.001_bib4) 2014; 63 Birnie (10.1016/j.jaci.2015.08.001_bib19) 2006; 54 Smith-Norowitz (10.1016/j.jaci.2015.08.001_bib17) 2012; 5 Ruggeberg (10.1016/j.jaci.2015.08.001_bib7) 2007; 25 Parisi (10.1016/j.jaci.2015.08.001_bib12) 2013; 43 Barbaud (10.1016/j.jaci.2015.08.001_bib14) 2013; 23 |
References_xml | – volume: 56 start-page: 922 year: 2001 end-page: 923 ident: bib21 article-title: Phenoxyethanol-induced urticaria publication-title: Allergy contributor: fullname: Bircher – volume: 130 start-page: 1213 year: 2012 end-page: 1216.e1 ident: bib2 article-title: Egg-allergic patients can be safely vaccinated against influenza publication-title: J Allergy Clin Immunol contributor: fullname: Carr – volume: 63 start-page: 691 year: 2014 end-page: 697 ident: bib4 article-title: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014-15 influenza season publication-title: MMWR Morb Mortal Wkly Rep contributor: fullname: Broder – volume: 927 start-page: 99 year: 2005 end-page: 134 ident: bib5 article-title: Recommendations for the production and control of influenza vaccine (inactivated) publication-title: WHO Technical Report Series – volume: 54 start-page: 349 year: 2006 ident: bib19 article-title: 2-phenoxyethanol-induced contact urticaria publication-title: Contact Dermatitis contributor: fullname: English – volume: 130 start-page: 1423 year: 2012 end-page: 1426 ident: bib18 article-title: Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE publication-title: J Allergy Clin Immunol contributor: fullname: Moore – volume: 98 start-page: 1058 year: 1996 end-page: 1061 ident: bib10 article-title: Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines publication-title: J Allergy Clin Immunol contributor: fullname: Inouye – volume: 23 start-page: 664 year: 2004 end-page: 667 ident: bib15 article-title: Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS) publication-title: Vaccine contributor: fullname: Tomazic-Jezic – volume: 125 start-page: 1412 year: 2010 end-page: 1413 ident: bib6 article-title: Ovalbumin content of influenza vaccines publication-title: J Allergy Clin Immunol contributor: fullname: Kita – volume: 20 start-page: 354 year: 2010 end-page: 355 ident: bib22 article-title: 2-phenoxyethanol-induced contact urticaria and anaphylaxis publication-title: J Investig Allergol Clin Immunol contributor: fullname: Boquete Paris – volume: 5 start-page: 111 year: 2012 end-page: 116 ident: bib17 article-title: Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study publication-title: J Inflamm Res contributor: fullname: Durkin – volume: 47 start-page: 54 year: 2002 ident: bib20 article-title: Contact urticaria from 2-phenoxyethanol publication-title: Contact Dermatitis contributor: fullname: Iglesias – volume: 16 start-page: 329 year: 1998 end-page: 334 ident: bib13 article-title: Major adverse reactions to yeast-derived hepatitis B vaccines—a review publication-title: Vaccine contributor: fullname: Shemer – volume: 2 start-page: e000186 year: 2012 ident: bib1 article-title: Reactions of Norwegian children with severe egg allergy to an egg-containing influenza A (H1N1) vaccine: a retrospective audit publication-title: BMJ Open contributor: fullname: Forsdahl – volume: 60 start-page: 777 year: 2015 end-page: 780 ident: bib9 article-title: Allergic reactions after egg-free recombinant influenza vaccine: reports to the US vaccine adverse event reporting system publication-title: Clin Infect Dis contributor: fullname: Woo – volume: 106 start-page: 591 year: 2000 end-page: 592 ident: bib11 article-title: Change in gelatin content of vaccines associated with reduction in reports of allergic reactions publication-title: J Allergy Clin Immunol contributor: fullname: Aizawa – volume: 43 start-page: 249 year: 2013 end-page: 254 ident: bib12 article-title: Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy publication-title: Clin Exp Allergy contributor: fullname: Docena – volume: 23 start-page: 135 year: 2013 end-page: 141 ident: bib14 article-title: Hypersensitivity and vaccines: an update publication-title: Eur J Dermatol contributor: fullname: Trechot – volume: 109 start-page: 426 year: 2012 end-page: 430 ident: bib3 article-title: Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy publication-title: Ann Allergy Asthma Immunol contributor: fullname: Sharma – volume: 25 start-page: 5675 year: 2007 end-page: 5684 ident: bib7 article-title: Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data publication-title: Vaccine contributor: fullname: Friedlander – volume: 41 start-page: 1367 year: 2011 end-page: 1370 ident: bib8 article-title: Influenza immunization in egg allergy: an update for the 2011-2012 season publication-title: Clin Exp Allergy contributor: fullname: Warner – volume: 8 start-page: 239 year: 2011 end-page: 244 ident: bib16 article-title: Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine publication-title: Int J Med Sci contributor: fullname: Durkin – volume: 41 start-page: 1367 year: 2011 ident: 10.1016/j.jaci.2015.08.001_bib8 article-title: Influenza immunization in egg allergy: an update for the 2011-2012 season publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2011.03842.x contributor: fullname: Erlewyn-Lajeunesse – volume: 2 start-page: e000186 year: 2012 ident: 10.1016/j.jaci.2015.08.001_bib1 article-title: Reactions of Norwegian children with severe egg allergy to an egg-containing influenza A (H1N1) vaccine: a retrospective audit publication-title: BMJ Open doi: 10.1136/bmjopen-2011-000186 contributor: fullname: Forsdahl – volume: 43 start-page: 249 year: 2013 ident: 10.1016/j.jaci.2015.08.001_bib12 article-title: Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy publication-title: Clin Exp Allergy doi: 10.1111/cea.12059 contributor: fullname: Parisi – volume: 98 start-page: 1058 year: 1996 ident: 10.1016/j.jaci.2015.08.001_bib10 article-title: Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(96)80191-6 contributor: fullname: Sakaguchi – volume: 23 start-page: 664 year: 2004 ident: 10.1016/j.jaci.2015.08.001_bib15 article-title: Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS) publication-title: Vaccine doi: 10.1016/j.vaccine.2004.06.042 contributor: fullname: Russell – volume: 130 start-page: 1213 year: 2012 ident: 10.1016/j.jaci.2015.08.001_bib2 article-title: Egg-allergic patients can be safely vaccinated against influenza publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.07.046 contributor: fullname: Des Roches – volume: 130 start-page: 1423 year: 2012 ident: 10.1016/j.jaci.2015.08.001_bib18 article-title: Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.07.019 contributor: fullname: Rouleau – volume: 63 start-page: 691 year: 2014 ident: 10.1016/j.jaci.2015.08.001_bib4 article-title: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014-15 influenza season publication-title: MMWR Morb Mortal Wkly Rep contributor: fullname: Grohskopf – volume: 927 start-page: 99 year: 2005 ident: 10.1016/j.jaci.2015.08.001_bib5 article-title: Recommendations for the production and control of influenza vaccine (inactivated) publication-title: WHO Technical Report Series – volume: 109 start-page: 426 year: 2012 ident: 10.1016/j.jaci.2015.08.001_bib3 article-title: Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2012.09.011 contributor: fullname: Greenhawt – volume: 60 start-page: 777 year: 2015 ident: 10.1016/j.jaci.2015.08.001_bib9 article-title: Allergic reactions after egg-free recombinant influenza vaccine: reports to the US vaccine adverse event reporting system publication-title: Clin Infect Dis doi: 10.1093/cid/ciu948 contributor: fullname: Woo – volume: 106 start-page: 591 year: 2000 ident: 10.1016/j.jaci.2015.08.001_bib11 article-title: Change in gelatin content of vaccines associated with reduction in reports of allergic reactions publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2000.108433 contributor: fullname: Nakayama – ident: 10.1016/j.jaci.2015.08.001_bib23 – volume: 54 start-page: 349 year: 2006 ident: 10.1016/j.jaci.2015.08.001_bib19 article-title: 2-phenoxyethanol-induced contact urticaria publication-title: Contact Dermatitis doi: 10.1111/j.0105-1873.2006.0645g.x contributor: fullname: Birnie – volume: 25 start-page: 5675 year: 2007 ident: 10.1016/j.jaci.2015.08.001_bib7 article-title: Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data publication-title: Vaccine doi: 10.1016/j.vaccine.2007.02.064 contributor: fullname: Ruggeberg – volume: 16 start-page: 329 year: 1998 ident: 10.1016/j.jaci.2015.08.001_bib13 article-title: Major adverse reactions to yeast-derived hepatitis B vaccines—a review publication-title: Vaccine doi: 10.1016/S0264-410X(97)00214-4 contributor: fullname: Grotto – volume: 23 start-page: 135 year: 2013 ident: 10.1016/j.jaci.2015.08.001_bib14 article-title: Hypersensitivity and vaccines: an update publication-title: Eur J Dermatol doi: 10.1684/ejd.2012.1842 contributor: fullname: Barbaud – volume: 20 start-page: 354 year: 2010 ident: 10.1016/j.jaci.2015.08.001_bib22 article-title: 2-phenoxyethanol-induced contact urticaria and anaphylaxis publication-title: J Investig Allergol Clin Immunol contributor: fullname: Nunez Orjales – volume: 8 start-page: 239 year: 2011 ident: 10.1016/j.jaci.2015.08.001_bib16 article-title: Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine publication-title: Int J Med Sci doi: 10.7150/ijms.8.239 contributor: fullname: Smith-Norowitz – volume: 47 start-page: 54 year: 2002 ident: 10.1016/j.jaci.2015.08.001_bib20 article-title: Contact urticaria from 2-phenoxyethanol publication-title: Contact Dermatitis doi: 10.1034/j.1600-0536.2002.470116.x contributor: fullname: Hernandez – volume: 125 start-page: 1412 year: 2010 ident: 10.1016/j.jaci.2015.08.001_bib6 article-title: Ovalbumin content of influenza vaccines publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.03.009 contributor: fullname: Li – volume: 5 start-page: 111 year: 2012 ident: 10.1016/j.jaci.2015.08.001_bib17 article-title: Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study publication-title: J Inflamm Res doi: 10.2147/JIR.S34152 contributor: fullname: Smith-Norowitz – volume: 56 start-page: 922 year: 2001 ident: 10.1016/j.jaci.2015.08.001_bib21 article-title: Phenoxyethanol-induced urticaria publication-title: Allergy doi: 10.1034/j.1398-9995.2001.00218.x contributor: fullname: Bohn |
SSID | ssj0009389 |
Score | 2.3862965 |
Snippet | Background Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza... Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine–associated... Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine-associated... BACKGROUNDInfluenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 861 |
SubjectTerms | Age Allergies Allergy and Immunology Anaphylaxis Anaphylaxis - immunology Antibody Specificity - immunology Antigens basophil activation Basophils - immunology Basophils - metabolism Case-Control Studies Child Child, Preschool Collaboration Egg Hypersensitivity - immunology Eggs Female hemagglutinin Hemagglutinin Glycoproteins, Influenza Virus - immunology Humans IgE Immunization Immunoglobulin E - blood Immunoglobulin E - immunology Influenza influenza vaccine Influenza Vaccines - adverse effects Influenza Vaccines - immunology Japan Male Patients Pediatrics Phosphoric Diester Hydrolases - metabolism Physicians Proteins Pyrophosphatases - metabolism Risk Factors Vaccination Vaccines |
Title | Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine–associated anaphylaxis |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0091674915010957 https://dx.doi.org/10.1016/j.jaci.2015.08.001 https://www.ncbi.nlm.nih.gov/pubmed/26365388 https://www.proquest.com/docview/1780627720 https://search.proquest.com/docview/1771448166 https://search.proquest.com/docview/1773913876 |
Volume | 137 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB6SDZReStJft0lQobfiRrJsST6GkLBpSU4N5CZkWSkOix3qTekPlL5D37BPkhlb3lDa5tCjZckSM5Lmk-ebEcArWQVy8OjUSaFSPH-VqSl8mToz5GvLTOAUjXxyquZn-dvz4nwNDqZYGKJVxr1_3NOH3TqW7EVp7l01DcX4lkShLxHSCAQKeh020Bzl-Qw29o_fzU9vc-9KM6LgUqTUIMbOjDSvS-cbYngVQybPeDfMX-zTv_DnYIeONuFBBJBsfxzjFqyF9iHcO4ku8kfwjZgbiy-saQkP9qFmC-IF9ay7YMcfDhlKsqk64g6yZcc-OU_NGDHLu5ZIFdiQTRHejP7SYsFwj8lXN9X-9eOni1rFz7uWUl4v3OemfwxnR4fvD-ZpvGEh9YVQyxTBXS0z8sVmodYl5xc5IoIq93moTC2MLzglqKecdFLlwpfcaSUE-QqVy3iQT2DW4uieAdNS1t7JWhbe5ypDpBGElhmepgpTGlck8HqSq70aE2nYiWF2aUkLlrRg6VJMLhLQk-jtFCKKm1ro4wrrrbB9Zrn9YxYkUKxa_jaRLNqIO3vcnjRsbzvRhtI464wn8HL1GhcgeVVcG7prqqNx0pH79c46shQSLU8CT8fZsxJCpqRCq2Oe_-fAX8B9fFIjL24bZsuP12EHgdKy2oX1N9_FblwON65VD54 |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwEB2VIgEbxLMEChiJHQqN48SPJapa3UJvV63UneU4Lkp1lVTkFrUgIf6BP-RLmEmcWyGgC7Z-xNaM7TnOnBkDvBZVIAePSp3gMsX7l0l16U3q9JCvLdcho2jk-YGcHRXvj8vjNdieYmGIVhnP_vFMH07rWLIVpbl11jQU42uIQm8Q0nAECuoG3CQ0QLyut9-ueB5G6BEDG55S8xg5M5K8Tp1viN9VDnk848swf7FO_0KfgxXavQd3I3xk78YZ3oe10D6AW_PoIH8IX4m3sbhkTUtosA81WxArqGfdCdv7uMNQjk3VEXOQLTv22XnqxohX3rVEqcCObIrvZvSPFguGV0y-uKn1z-8_XNQpft61lPB64S6a_hEc7e4cbs_S-L5C6ksulylCu1rk5InNQ61Mlp0UiAeqwheh0jXXvswoPT1lpBOy4N5kTknOyVMoXZ4F8RjWW5zdE2BKiNo7UYvS-0LmiDMCVyLHu1SpjXZlAm8mudqzMY2Gnfhlp5a0YEkLlp7EzHgCahK9nQJE8UgLfdxfveW2z21m_1gDCZSrnr8tI4sW4toRNycN26tBlKYkzirPEni1qsbtRz4V14bunNoovJKS8_XaNsJwgXYngY1x9ayEkEsh0ebop_858Zdwe3Y437f7ewcfnsEdrJEjQ24T1pefzsNzhEzL6sWwJX4BGmMQcw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Highly+increased+levels+of+IgE+antibodies+to+vaccine+components+in+children+with+influenza+vaccine-associated+anaphylaxis&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Nagao%2C+Mizuho&rft.au=Fujisawa%2C+Takao&rft.au=Ihara%2C+Toshiaki&rft.au=Kino%2C+Yoichiro&rft.date=2016-03-01&rft.pub=Elsevier+Limited&rft.issn=0091-6749&rft.eissn=1097-6825&rft.volume=137&rft.issue=3&rft.spage=861&rft_id=info:doi/10.1016%2Fj.jaci.2015.08.001&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=4020560541 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674916X00024%2Fcov150h.gif |